Pharmaceutical anti - Buprenorphine Mouse Monoclonal Antibody for IVD research

Pharmaceutical anti - Buprenorphine Mouse Monoclonal Antibody for IVD research

Background:

Buprenorphine (C29 H41 NO4) is a prescription medication for people addicted to heroin or other opiates that acts by relieving the symptoms of opiate withdrawal such as agitation, nausea and insomnia. Buprenorphine is more weakly addictive and has a lower risk of overdose than methadone. The effects last for about three days.

Specification:

Product Overview: Monoclonal Antibody to Buprenorphine

Specificity: Buprenorphine

Immunogen: BUP-BSA conjugate

Isotype: IgG₁

Host animal: Mouse

Source: Ascites

Format: Purified, Lyophilized, Reconstitute in 100ul double distilled water.

Applications: Specific methodologies have not been tested using this product.

Purification: >95% pure (SDS-PAGE)

Affinity Constant: Not determined

Packing:

Concentration: 3.91mg/ml (OD280nm, E^0.1% = 1.4)

Buffer: PBS, pH 7.0

Preservative: 0.02% Sodium azide

Storage: Store lyophilized product at 2-8°C. After reconstitution, store at -20°C. Avoid multiple freeze/ thaw cycles.

Warning: This product contains sodium azide, which has been classified as Xn (Harmful) in European Di-rective 67/548/EEC in the concentration range of 0.1– 1.0%. When disposing of this reagent through lead or copper plumbing, flush with copious volumes of water to prevent azide build-up in drains.

Established in 2009, Orient New Life Medical Co., Ltd., is specialized in high-tech biological diagnostic test development, research and production, as well as high-tech medical device development, research and production. New Life has built up two production base, which produce biological diagnostic test and endoscopic medical device respectively. Our products ranged in the following specialties: drug of abuse tests, fertility tests, infectious diseases tests, sexual transmitted diseases tests, tumor markers tests, cardiac markers tests, veterinary tests, and surgical stapler series.

NEW LIFE have 3 wholly-owned and joint stock subsidiary companies, including Orient New Life Medical  Co., Ltd., Orient Gene Biotech Co., Ltd., Qianjing Medical Equipment Co., Ltd.

Company's core technical team with more than 35 employees，3 doctors and 25 masters. They have many years of famous universities in the United States and pharmaceutical companies engaged in the project research and development, production and marketing, business management experience.Company owns hundreds of grade purification workshop and all level of quality checkout room, equipped with various production and testing equipment.